Project Details
Abstract
The purpose of this randomized controlled trial will be to examine (1) the effects of a
hybrid therapy (ie, mirror therapy combined with transcranial direct current stimulation,
MT+ tDCS) on health-related outcomes in patients with chronic stroke from pre- to
post-treatment; (2) the long-term benefits of the hybrid therapy on activity participation at
6-month follow-up; (3) the underlying mechanisms of the hybrid therapy on brain
organization and motor control; and (4) the correlations between brain excitability patterns
and movement kinematics as well as health-related outcomes. To achieve the aims, we will
study the effects of MT combined with tDCS compared to MT with sham tDCS, MT alone,
and conventional intervention (CI) on motor performance, daily function, and activity
participation. We will also examine the underlying mechanism of change in brain plasticity
and motor control by functional magnetic resonance imaging (fMRI) analyses and kinematic
analysis, respectively.
Contemporary approaches to upper limb motor rehabilitation such as robot-assisted
therapy and constraint-induced therapy are effective for reducing motor impairments but are
limited by practical constraints. These therapies either require intensive engagement or are
expensive to apply in clinical settings. MT is inexpensive and applicable in clinical settings.
This regimen is versatile for clinical use because of its compatibility with adjunct procedures
such as somatosensory stimulation and transcranial stimulation. MT and tDCS are both
based upon principles of rehabilitation for inducing neuroplastic change. Both regimens have
been shown to be effective for promoting motor recovery after stroke. tDCS does not require
patients’ efforts and can be used to activate a bulk of neural circuits in a non-specific way.
Coupling tDCS with MT could steer plastic process toward greater functional recovery.
Current evidence is insufficient to support the efficacy of tDCS as an adjuvant to upper limb
intervention. In addition, long-term effects of the hybrid therapy have yet to be explored.
At least 80 participants with chronic stroke will be recruited and randomly assigned to
one of 4 groups: MT with tDCS, MT with sham tDCS, MT only, and CI. All the
interventions will be implemented 90 minutes/day, 5 days/week, for 4 weeks. MT with real
and sham tDCS groups will receive 60-minute MT with concurrent real or shame tDCS
during the first 30 minutes, and then followed by 30-minute functional training. The MT
group will receive 60-minute MT, followed by 30-minute functional training. The CI group
will receive 60-minute conventional rehabilitation followed by 30-minute functional task
practice. Outcome measures of sensorimotor function will include Fugl-Meyer Assessment
and Revised Nottingham Sensory Assessment. Motor and daily functions, and activity
participation will be assessed based on Wolf Motor Function Test, Motor Activity Log
(MAL), Reintegration to Normal Living Index (RNLI), and Adelaide Activities Profile
(AAP). Brain reorganization and motor control strategy will be assessed by fMRI study and
kinematic analysis. Evaluators will be blinded to group allocation. A 6-month follow-up will
be conducted for the re-evaluation of MAL, RNLI, and AAP.
This study is unique in investigating the effects of the hybrid therapy (MT+tDCS) using
a placebo-controlled trial. This research will be the first to study multiple treatment
endpoints that correspond to different levels of functional outcomes, as well as brain and
movement organization. The result of this research may shed light on the additive benefits of
combinatory treatment relative to the stand-alone therapy. The follow-up examination will
provide information on the retention or dilution of treatment effect on daily functions and
activity participation, which are crucial for community reentry. Study of brain activity and
movement pattern control may have implications for mechanism of change after treatment.
Results of this research may lead to refined protocols of combinatory treatment based on
MT and electrical stimulations.
Project IDs
Project ID:PC10501-1383
External Project ID:MOST103-2314-B182-004-MY3
External Project ID:MOST103-2314-B182-004-MY3
Status | Finished |
---|---|
Effective start/end date | 01/08/16 → 31/07/17 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.